Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
archives
»
Monthly Archive
» January 2011
January 2011
Sun Pharma Q3 PAT seen up 32% to Rs 446 cr
Sun Pharma Q3 PAT seen up 32% to Rs 446 cr
Money Control, India
Sun Pharma
Zydus, Bayer Healthcare enter 50:50 venture
Zydus, Bayer Healthcare enter 50:50 venture
Business Standard
Bayer
Zydus Cadila
Angiotech To File For Bankruptcy
Angiotech To File For Bankruptcy
RTT News
Angiotech
bankruptcy
A Closer Look at ... Allergan, Merck, and Pfizer
A Closer Look at ... Allergan, Merck, and Pfizer
Schaeffer's Investment Research
Allergan
Merck
Pfizer
investors
BiPar breast cancer drug fails late-stage trial
BiPar breast cancer drug fails late-stage trial
bizjournals.com
BiPar
breast cancer
iniparib
J&J Hip Replacement Plaintiff Committee Lawyers Named by Judge in Ohio
J&J Hip Replacement Plaintiff Committee Lawyers Named by Judge in Ohio
Bloomberg
JNJ
lawsuits
Looking Ahead at Bristol-Myers
Looking Ahead at Bristol-Myers
Motley Fool
Bristol-Myers Squibb
investors
Avoid This Falling Knife for Now (Eli Lilly)
Avoid This Falling Knife for Now (Eli Lilly)
Motley Fool
Eli Lilly
investors
Celgene Needs a Rocket Ship
Celgene Needs a Rocket Ship
Motley Fool
Celgene
Abraxane
Pfizer Ordered to Pay $142.1 Million Over Neurontin `Off-Label' Marketing
Pfizer Ordered to Pay $142.1 Million Over Neurontin `Off-Label' Marketing
Bloomberg
Pfizer
off label
Neurontin
settlements
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »